Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Maria Neofytou


Postdoctoral Researcher

I am a postdoctoral researcher in the Clinical Genetics group of Professors Andrew Wilkie and Anne Goriely.

My scientific interests focus on translational research and technology development for early non-invasive diagnostic testing towards a larger goal of personalised medicine. In our lab, we have developed state-of-the-art assays such as targeted next-generation sequencing (NGS) assays to reliably detect and quantify low abundance mutations for early cancer detection, (liquid biopsy), as well as non-invasive prenatal testing (NIPT) of severe disorders.

Using non-invasive genetic testing for deleterious mutations during pregnancy enables us to apply a screening approach to address biological questions related to the “paternal age effect” and the birth prevalence of rare Mendelian diseases.

 I earned my PhD at the Cyprus Institute of Neurology and Genetics where I employed targeted next-generation sequencing for prenatal testing of microdeletion syndromes. Following this, I joined the group of Joris Vermeeesch in KU Leuven in Belgium and I was involved in various projects from early cancer detection in elderly people, to non-invasive testing for single gene disorders during pregnancy.